iCAD, Inc. is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) imaging. The Company operates in two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). The Detection segment consists of the Company's advanced image analysis and workflow products, and the Therapy segment consists of its radiation therapy products. The Company sells its products throughout the world through its direct sales organization, as well as through various original equipment manufacturer (OEM) partners, distributors and resellers.